Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-VEGF Therapy Versus Dexamethasone Implant for Treatment Naive Diabetic Macular Edema: A Randomized Controlled Trial

NCT03999125 is registered in ClinicalTrials.gov with Sudhalkar Eye Hospital as lead sponsor.

NCT NCT03999125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03999125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-VEGF Therapy Versus Dexamethasone Implant for Treatment Naive Diabetic Macular Edema: A Randomized Controlled Trial
Lead sponsor
Sudhalkar Eye Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 25, 2019
Completion date
June 24, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically significant macular edema due to diabetes mellitus